4
Changes in Ownership
Lexaria Bioscience Corp. Filed Acc 0001103780-16-000082
CEO bought 12,000 shares at an average $0.11 ($1,360)
From the SEC's structured data for this filing
Trades in this filing
BUNKA CHRISTOPHER · CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-07-13 | Purchase : show line 1 in the form | +5,000 | $0.13 | $650 | 7,024,314 | D |
| 2016-07-13 | Purchase : show line 2 in the form | +5,000 | $0.10 | $500 | 7,029,314 | D |
| 2016-07-13 | Purchase : show line 3 in the form | +2,000 | $0.11 | $210 | 7,031,314 | D |
| Open-market purchases · 12,000 sh · avg $0.11 · $1,360 | ||||||
Loading xslF345X03/primary_doc.xml…